Watchlist Price Alert

Xenon Pharmaceuticals Inc... (XENE)

NASDAQ: XENE · Real-Time Price · USD

31.90

-0.12 (-0.37%)

At close: Jun 17, 2025, 10:52 AM

Xenon Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	n/a	n/a	9.43M	18.44M	32.17M	6.83M	n/a	311K	1.8M
Cost of Revenue	2.56M	167.51M	105.77M	75.46M	50.52M	38.84M	6M	25.57M	1.11M
Gross Profit	n/a	-167.51M	-96.33M	-57.03M	-18.36M	-32.02M	-6M	-25.26M	689K
Operating Income	-279.3M	-214.05M	-129.14M	-78.99M	-31.3M	-42.82M	-38.02M	-32.58M	-24.82M
Interest Income	41.94M	27.62M	8.71M	466K	2.28M	2.35M	1.22M	477K	504K
Pretax Income	-238.42M	-182.69M	-125.25M	-78.89M	-29.09M	-41.62M	-34.5M	-30.7M	-23M
Net Income	-234.33M	-182.39M	-125.37M	-78.88M	-28.84M	-41.59M	-34.5M	-30.7M	-23M
Selling & General & Admin	68.9M	46.54M	32.81M	21.97M	12.94M	10.8M	8.38M	7.31M	6.79M
Research & Development	210.39M	167.51M	105.77M	75.46M	50.52M	38.84M	23.63M	25.57M	19.83M
Other Expenses	n/a	-167.51M	3.89M	105K	2.21M	n/a	4.4M	n/a	n/a
Operating Expenses	279.3M	46.54M	138.58M	97.43M	63.47M	49.65M	32.02M	32.89M	26.62M
Interest Expense	n/a	n/a	n/a	n/a	484K	1.43M	1.39M	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	214.05M	138.58M	97.43M	63.47M	49.65M	38.02M	32.89M	26.62M
Income Tax Expense	-4.09M	-292K	118K	-6K	-257K	-23K	4.91M	-1.87M	-1.82M
Shares Outstanding (Basic)	77.89M	66.89M	60.54M	43.63M	34.54M	25.94M	19.43M	17.99M	15.49M
Shares Outstanding (Diluted)	77.89M	66.89M	60.54M	43.63M	34.54M	25.94M	19.43M	18M	15.49M
EPS (Basic)	-3.01	-2.73	-2.07	-1.81	-0.83	-1.6	-1.78	-1.71	-1.48
EPS (Diluted)	-3.01	-2.73	-2.07	-1.81	-0.83	-1.6	-1.78	-1.71	-1.48
EBITDA	-235.86M	-210.51M	-127.52M	-78.09M	-27.97M	-39.76M	-32.54M	-30.05M	-23.95M
EBIT	-238.42M	-214.05M	-129.14M	-78.99M	-28.61M	-40.18M	-33.13M	-30.7M	-24.82M
Depreciation & Amortization	2.56M	3.54M	1.62M	906K	644K	429K	586K	649K	864K